Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome (Q81140679)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16133051%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16133051%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

1 reference

Kandai Nozu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16133051%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Kazumoto Iijima

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16133051%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Masato Fujisawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16133051%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Atsuko Nakagawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16133051%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Norishige Yoshikawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16133051%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Masafumi Matsuo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16133051%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

16 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16133051%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16133051%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16133051%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

1660-1663

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16133051%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16133051%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00467-005-2013-7

6 January 2020

exact match

0 references

cites work

Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study

1 reference

12 December 2020

Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.

1 reference

12 December 2020

Recurrent focal glomerulosclerosis: natural history and response to therapy

1 reference

12 December 2020

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy

1 reference

12 December 2020

Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome

1 reference

12 December 2020

Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies

1 reference

12 December 2020

Prompt remission of post-renal transplant nephrotic syndrome with high-dose cyclosporine

1 reference

12 December 2020

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

1 reference

12 December 2020

Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome.

1 reference

12 December 2020

Immunodeficiency-related lymphoproliferative disorders: prospective data from the United Kingdom Children's Cancer Study Group Registry

1 reference

12 December 2020

Rituximab in idiopathic membranous nephropathy: a one-year prospective study

1 reference

12 December 2020

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

1 reference

12 December 2020

Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation.

1 reference

12 December 2020

Nephrotic syndrome in a patient with intravascular lymphomatosis

1 reference

12 December 2020

Rituximab in the treatment of pediatric small bowel transplant patients with posttransplant lymphoproliferative disorder unresponsive to standard treatment

1 reference

12 December 2020

European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.5. Chronic graft dysfunction. Late recurrence of primary glomerulonephritides

1 reference

12 December 2020

Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis

1 reference

12 December 2020

Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children.

1 reference

12 December 2020

A glomerular permeability factor produced by human T cell hybridomas

1 reference

12 December 2020

Treatment of posttransplant lymphoproliferative disorder with the anti-CD20 monoclonal antibody rituximab alone in an adult after liver transplantation: a new drug in therapy of patients with posttransplant lymphoproliferative disorder after solid o

1 reference

12 December 2020

Recurrence of primary renal disease on kidney graft: a European pediatric experience

1 reference

12 December 2020

Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: successful treatment with oral cyclophosphamide.

1 reference

12 December 2020

Long-Term Evaluation of Children with Nephrotic Syndrome and Focal Segmental Glomerular Sclerosis

1 reference

12 December 2020

Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients

1 reference

12 December 2020

High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children

1 reference

12 December 2020